Basics Phathom Pharmaceuticals, Inc. IPO Date: October 21, 2019 Sector: Healthcare Industry: Biotech Market Cap: $287.63M Activated in VL: True Average Daily Range Avg Daily Range: $0.65 | 3.58% Avg Daily Range (30 D): $0.21 | 6.18% Avg Daily Range (90 D): $0.26 | 5.60% Institutional Daily Volume Avg Daily Volume: .36M Avg Daily Volume (30 D): 1.74M Avg Daily Volume (90 D): 1.31M Trade Size Avg Trade Size (Sh.): 89 Avg Trade Size (Sh.) (30 D): 134 Avg Trade Size (Sh.) (90 D): 115 Institutional Trades Total Inst.Trades: 651 Avg Inst. Trade: $1.49M Avg Inst. Trade (30 D): $.99M Avg Inst. Trade (90 D): $.96M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.51M Avg Closing Trade (30 D): $1.09M Avg Closing Trade (90 D): $.8M Avg Closing Volume: 103.21K         News Apr 16, 2025 @ 12:00 PM Phathom Pharmaceuticals Appoints Ted Schroeder to ... Source: N/A Apr 1, 2025 @ 12:00 PM Phathom Pharmaceuticals Announces Leadership Succe... Source: N/A Mar 6, 2025 @ 1:00 PM Phathom Pharmaceuticals Reports Fourth Quarter and... Source: N/A Jan 29, 2025 @ 1:00 PM Phathom Pharmaceuticals to Present at the Guggenhe... Source: N/A Oct 28, 2024 @ 12:00 PM Phathom Pharmaceuticals to Report Third Quarter 20... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-5.19 $-1.31 $-1 Diluted EPS $-5.19 $-1.31 $-1 Revenue $ 81.86M $ 28.52M $ 29.66M Gross Profit $ 70.59M $ 24.8M $ 25.85M Net Income / Loss $ -345.79M $ -94.32M $ -74.45M Operating Income / Loss $ -286.38M $ -78.86M $ -59.42M Cost of Revenue $ 11.27M $ 3.72M $ 3.82M Net Cash Flow $ -24.97M $ M $ -37.42M PE Ratio